Latest Breaking News On - Phathom pharmaceuticals - Page 4 : comparemela.com

Stock Analysts Updated EPS Estimates for May 3rd (ASLN, ASUR, BCYC, BILL, BMEA, CDXS, COIN, DYN, ECVT, EXEL)

Stock Analysts Updated EPS Estimates for May 3rd (ASLN, ASUR, BCYC, BILL, BMEA, CDXS, COIN, DYN, ECVT, EXEL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairCanaccord genuity group incJazz pharmaceuticalsNeedham companyBarrington researchUpland softwarePhathom pharmaceuticalsAg mortgage investment trustExpedia groupAsure softwarePharmaceuticals limited dailyStock analystCanaccord genuity groupTyr pharmaInvestment trustLimited daily

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesTel avivFlorham parkPhathom pharmaceuticalsNews ratings for phathom pharmaceuticals dailyNeurosense therapeutics ltdPhathom pharmaceuticals incGet free reportNeurosense therapeuticsGiven phathom pharmaceuticalNeurosense therapeuticSense therapeuticsSense therapeutics ltdPhathom pharmaceuticals daily

Phathom Pharmaceuticals (PHAT) Scheduled to Post Quarterly Earnings on Thursday

Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) will release its earnings data before the market opens on Thursday, May 9th. Analysts expect Phathom Pharmaceuticals to post earnings of ($1.13) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Phathom Pharmaceuticals (NASDAQ:PHAT – Get […]

United statesMolly hendersonTerrie curranEarnings history for phathom pharmaceuticalsNeedham companySecurities exchange commissionNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals price performancePhathom pharmaceuticals incPhathom pharmaceuticalsGet free reportExchange commissionPhathom pharmaceuticals dailyNasdaq phat

Phathom Pharmaceuticals (PHAT) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]

New zealand generalNew zealandUnited statesMolly hendersonTerrie curranChina universal asset management coBarclays plcInstitutional trading of phathom pharmaceuticalsInsider activity at phathom pharmaceuticalsNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals incPhathom pharmaceuticalsNeedham companyPhathom pharmaceuticals stockWellington management groupPrincipal financial group inc

Investment Opportunities In Biotech Amidst Federal Rate Uncertainties (ATNM)

Investment Opportunities In Biotech Amidst Federal Rate Uncertainties (ATNM)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomGlasgow cityBristol meyersNovo nordiskGroup fedwatchRhythm pharmaceuticalsPhathom pharmaceuticalsExchange commissionFederal reserveEuropean bone marrow transplant society meetingMorgan stanleyActinium pharmaceuticals incActinium pharmaceuticalsEli lillyBiotech performanceNasdaq biotechnology index